Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2024BiomedicinesOpen Access

Microbial Signatures in COVID-19: Distinguishing Mild and Severe Disease via Gut Microbiota

View Full Paper
Ask AI
Bookmark
Share

Authors

JGJulia S. GaleevaMoscow Center For Continuous Mathematical EducationDFDmitry E. FedorovMoscow Center For Continuous Mathematical EducationESElizaveta V. StarikovaInstitute for Systems Biology

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Galeeva et al. (2024) studied this question.

synapsesocial.com/papers/68e6c033b6db64358763f916https://doi.org/10.3390/biomedicines12050996
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza2020 · 855 citations
  2. 2Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium2004 · 2,128 citations
  3. 3Dirichlet Multinomial Mixtures: Generative Models for Microbial Metagenomics2012 · 965 citations
  4. 4A Combination of Formic Acid and Monolaurin Attenuates Enterotoxigenic Escherichia coli Induced Intestinal Inflammation in Piglets by Inhibiting the NF-κB/MAPK Pathways with Modulation of Gut Microbiota2020 · 53 citations
  5. 5Regulation of intestinal epithelial intercellular adhesion and barrier function by desmosomal cadherin desmocollin-22021 · 44 citations